Omnia Biologics And Prolong Sign Production Services Agreement

ROCKVILLE, Md.--(BUSINESS WIRE)--Jan. 24, 2006--Biologics contract manufacturer Omnia Biologics, Inc. (Omnia) (Rockville, MD) and biopharmaceutical drug development company Prolong Pharmaceuticals, Inc. (Monmouth Junction, NJ) today announced signing of a production services agreement for Omnia to provide Prolong with sterile fill-finish services.

MORE ON THIS TOPIC